CFDs are a leveraged product and can result in losses that exceed deposits. Trading CFDs may not be suitable for everyone, so please ensure you fully understand the risks and take care to manage your exposure.

Australia's Medibank Private reports 1% net profit drop

Australia’s Medibank Private has reported a net profit of $445 million, down 1% from $449.5 million last year.

CFDs are a leveraged product and can result in losses that exceed deposits. Trading CFDs may not be suitable for everyone, so please ensure you fully understand the risks and take care to manage your exposure.
Medibank_small
Source: Medibank

Medibank Australia reports its net profit drop was due to lower equity and credit market returns.

Medibank's net investment income has decreased 3.1% to $95.6 million, with stock posts its biggest intraday fall since June 2016.

Operating profit in health insurance jumped 7.7% to $536 million, with a revenue growth of 1.2%.

While there’s been a 1% drop net income, the report shows Medibank's health insurance business seems to be turning around.

Medibank Private chief executive Craig Drummond agrees. Mr Drummond says he’s pleased with the growth progress.

'This result demonstrates that our core health insurance business is back on track and in the coming year we will continue to transform our relationship with our customers and deliver a more personalised and proactive experience.’ Said Mr Drummond.

Health insurance operating profit is reported at $535.6 million up 7.7 %, with a $38 million increase.

Another fall however, with the net investment income falling by 31.4% to $95.6 million, showing lower returns across growth and defensive portfolios.

This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.  Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. 

CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.